申请人:Novo Nordisk Health Care AG
公开号:US20150250882A1
公开(公告)日:2015-09-10
The present invention relates to growth hormone compositions comprising a fatty acid acylated amino acids (FA-aa's), which may be used in pharmaceutical compositions such as pharmaceutical compositions for oral administration of growth hormone.